Education
About Us
Working with TipRanks
Follow Us
Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170)
:2170
2170 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.74 - HK$4.45
Previous CloseN/A
Volume107.50K
Average Volume (3M)841.72K
Market Cap
HK$836.99M
Enterprise ValueHK$551.32M
Total Cash (Recent Filing)HK$684.63M
Total Debt (Recent Filing)HK$328.42M
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding82,713,840
10 Day Avg. Volume322,650
30 Day Avg. Volume841,716
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.00Price Target Upside-1.96% Downside
Rating ConsensusHold
Number of Analyst Covering0
Suzhou Basecare Medical Corp. Ltd. Class H News
2170 FAQ
What was Suzhou Basecare Medical Corp. Ltd. Class H’s price range in the past 12 months?
Suzhou Basecare Medical Corp. Ltd. Class H lowest stock price was HK$1.74 and its highest was HK$4.45 in the past 12 months.
What is Suzhou Basecare Medical Corp. Ltd. Class H’s market cap?
Suzhou Basecare Medical Corp. Ltd. Class H’s market cap is HK$836.99M.
When is Suzhou Basecare Medical Corp. Ltd. Class H’s upcoming earnings report date?
Suzhou Basecare Medical Corp. Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 178 days.
How were Suzhou Basecare Medical Corp. Ltd. Class H’s earnings last quarter?
Suzhou Basecare Medical Corp. Ltd. Class H released its earnings results on Aug 29, 2025. The company reported -HK$0.437 earnings per share for the quarter, the consensus estimate of -HK$0.437 by HK$0.
Is Suzhou Basecare Medical Corp. Ltd. Class H overvalued?
According to Wall Street analysts Suzhou Basecare Medical Corp. Ltd. Class H’s price is currently Overvalued.
Does Suzhou Basecare Medical Corp. Ltd. Class H pay dividends?
Suzhou Basecare Medical Corp. Ltd. Class H does not currently pay dividends.
What is Suzhou Basecare Medical Corp. Ltd. Class H’s EPS estimate?
Suzhou Basecare Medical Corp. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suzhou Basecare Medical Corp. Ltd. Class H have?
Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding.
What happened to Suzhou Basecare Medical Corp. Ltd. Class H’s price movement after its last earnings report?
Suzhou Basecare Medical Corp. Ltd. Class H reported an EPS of -HK$0.437 in its last earnings report, expectations of -HK$0.437. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Suzhou Basecare Medical Corp. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2170
Suzhou Basecare Medical Corp. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$3.00 (-1.96% Downside)
HK$3.00 (-1.96% Downside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
105.36%
12-Months-Change
Fundamentals
Return on Equity
-20.60%
Trailing 12-Months
Asset Growth
-11.13%
Trailing 12-Months
Company Description
Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corp. Ltd. Class H (2170) is a China-based biotechnology company specializing in genetic testing and precision medicine. The company provides comprehensive solutions and services in the fields of reproductive health, oncology, and other genetic disorders. Leveraging advanced technologies and a robust R&D infrastructure, Suzhou Basecare Medical Corp. aims to enhance diagnostic accuracy and therapeutic outcomes for its healthcare partners and patients.
Technical Analysis
Peijia Medical Ltd.
―
MicroPort CardioFlow Medtech Corp.
―
Broncus Holding Corp.
―
MicroTech Medical (Hangzhou) Co., Ltd. Class H
―
Venus Medtech (Hangzhou), Inc. Class H
―